Ovarian Cancer Research Fund.  Comparative immunohistochemical studies of endometriosis lesions & carcinomas arising in endometriomas.  PI with Dr. Farr Nezhat (OB/GYN)

Endometriosis Foundation.  Immunohistochemical studies of endometriosis lesions using a neoplasia model.  Co PI with Dr. Farr Nezhat (OB/GYN)

Gynecologic  Cancer Research Fund. Molecular biologic investigations of ovarian cancer, using gene microarray.  Co-I with Dr. S. Kohtz (Pathology) .

Ruttenberg Fellowship:  Functional and structural studies of the nuclear membrane pore complex in ovarian cancer.  Co-I with S. Kohtz, Yayoi Kinoshita (Pathology).

NIH IRO3CA 141318-01A1.  Nuclear Pore Complex Architecture & Drug Resistance in Ovarian Carcinomas.    Co-I with S. Kohtz and Y. Kinoshita (Pathology)

NIH-NIAID: Population Council, ID: IF1574980.  Ex vivo anti-HIV microbicides efficacy testing using cervico-vaginal tissues.  Co-I with PI Rhoda Sperling and Natalia Teleshova (OB/GYN)

NIH-NIAID (R01).RFA-HD-008. Effect of sex hormones on HIV infection of cervical and rectal mucosal tissue.  Co-I with Drs. Rhoda Sperling and Natalia Teleshova (OB/GYN)

Pending:  Utility of POLE as a Prognostic Marker for Type II (High-Grade) Endometrial and Ovarian Cancers.  Co-PI  Farr Nezhat, and Yuxin Liu

Interdepartmental (Pathology/OB-GYN, with GYN Oncology Fellows Joel Cardenas and Longduc Nguyen), and Medical Student Bluestein Scholarly Project (Anna Lee).  Multiplex immunofluorescence studies of potential prognostic markers in ovarian cancers.  Co-I with Drs. Michael Donovan & Carlos Cordon-Cardo (Pathology), and Dr. David Fishman & Peter Dottino (OB/GYN)